JD Health International Inc. reported no change in its total authorized share capital for November 2025, which remained at 100,000,000,000 ordinary shares with an aggregate par value of USD 50,000. The issued share count stood at 3,201,475,111 at the end of the previous month and increased to 3,209,275,111.

According to the filing, 7,800,000 new shares were issued under the Post-IPO Share Award Scheme, while the Pre-IPO ESOP did not lead to any additional share issuance, as the exercised options were satisfied by previously issued shares. No treasury shares were reported. The total number of issued shares at the end of November 2025 was 3,209,275,111.